In non-recurring tumors, the tumor margins displayed a significantly higher CD8 T-cell presence than in recurring tumors (p=0.0097, Figure 1F), while immune cell presence in tumor and stroma did not inform clinical outcome in untreated tumors. This evidence concerns the gene CD8A and neoplasm.